Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capsimax is a concentrated, encapsulated extract of capsaicinoids derived from red chili peppers (Capsicum annum), developed by OmniActive Health Technologies. It is designed to deliver the metabolic benefits of capsaicinoids—such as increased resting energy expenditure (REE), enhanced lipolysis, and appetite suppression—without the oral and gastric irritation typically associated with unprotected red pepper extracts. By utilizing a controlled-release coating (OmniBead technology), Capsimax ensures the capsaicinoids are released in the lower intestine rather than the stomach. Clinical studies have demonstrated its efficacy in increasing metabolic rate in both fed and fasting conditions, supporting its use in weight management and sports nutrition formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Capsimax.